#dostarlimab — Public Fediverse posts

Surgery-Free Rectal Cancer Treatment Edges Closer as Dostarlimab Clears Registrational Trial

GSK announced Sunday that dostarlimab (Jemperli), its PD-1–blocking immunotherapy, met the primary endpoint of the AZUR-1 registrational Phase…
#EuropeSays #Britain #Europe #EU #GSK #AZUR-1trial #cancertreatment #dostarlimab #FDAapproval #immunotherapy #Jemperli #rectalcancer
https://www.europesays.com/britain/82987/

https://www.europesays.com/britain/82987/ Surgery-Free Rectal Cancer Treatment Edges Closer as Dostarlimab Clears Registrational Trial #AZUR1Trial #CancerTreatment #dostarlimab #FDAApproval #GSK #immunotherapy #Jemperli #RectalCancer

GSK reports Jemperli rectal cancer trial results

GSK reported positive interim results from the AZUR-1 Phase II trial of Jemperli in dMMR/MSI-H locally advanced rectal…
#EuropeSays #Britain #Europe #EU #GSK #AZUR-1trial #Biotechnology #cancertreatment #dostarlimab #GSKplc #immunotherapy #Jemperli #Oncology #rectalcancer
https://www.europesays.com/britain/82130/

https://www.europesays.com/britain/82130/ GSK reports Jemperli rectal cancer trial results #AZUR1Trial #Biotechnology #CancerTreatment #dostarlimab #GSK #GSKPlc #immunotherapy #Jemperli #Oncology #RectalCancer

GSK’s Jemperli meets main goal in mid-stage rectal cancer trial

GSK said on Monday its cancer drug Jemperli met the primary goal of a mid-stage trial, with a…
#EuropeSays #Britain #Europe #EU #GSK #AZUR-1trial #cancerdrugapproval #chemotherapyalternatives #ClinicalTrialResults #dostarlimab #immunotherapy #Jemperli #mid-stagetrial #rectalcancertrial
https://www.europesays.com/britain/81923/

https://www.europesays.com/britain/81923/ GSK’s Jemperli meets main goal in mid-stage rectal cancer trial #AZUR1Trial #CancerDrugApproval #ChemotherapyAlternatives #ClinicalTrialResults #dostarlimab #GSK #immunotherapy #Jemperli #MidStageTrial #RectalCancerTrial